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Aims Magnetic resonance imaging (MRI) is the gold standard for defining myocardial substrate in 3D and can be used to
guide ventricular tachycardia ablation. We describe the feasibility of using a prototype magnetic resonance-guided
electrophysiology (MR-EP) system in a pre-clinical model to perform real-time MRI-guided epicardial mapping, abla-
tion, and lesion imaging with active catheter tracking.
...................................................................................................................................................................................................
Methods
and results
Experiments were performed in vivo in pigs (n= 6) using an MR-EP guidance system research prototype (Siemens
Healthcare) with an irrigated ablation catheter (Vision-MR, Imricor) and a dedicated electrophysiology recording
system (Advantage-MR, Imricor). Following epicardial access, local activation and voltage maps were acquired, and
targeted radiofrequency (RF) ablation lesions were delivered. Ablation lesions were visualized in real time during
RF delivery using MR-thermometry and dosimetry. Hyper-acute and acute assessment of ablation lesions was also
performed using native T1 mapping and late-gadolinium enhancement (LGE), respectively. High-quality epicardial bi-
polar electrograms were recorded with a signal-to-noise ratio of greater than 10:1 for a signal of 1.5 mV. During
epicardial ablation, localized temperature elevation could be visualized with a maximum temperature rise of 35 C
within 2 mm of the catheter tip relative to remote myocardium. Decreased native T1 times were observed
(882 ± 107 ms) in the lesion core 3–5 min after lesion delivery and relative location of lesions matched well to LGE.
There was a good correlation between ablation lesion site on the iCMR platform and autopsy.
...................................................................................................................................................................................................
Conclusion The MR-EP system was able to successfully acquire epicardial voltage and activation maps in swine, deliver, and
visualize ablation lesions, demonstrating feasibility for intraprocedural guidance and real-time assessment of ablation
injury.
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Introduction
Radiofrequency (RF) catheter ablation reduces recurrences of ven-
tricular tachycardia (VT) and appropriate implantable cardioverter
defibrillator (ICD) therapies in patients with ischaemic1,2 and non-
ischaemic cardiomyopathy.3 However, catheter ablation is still limited
by relatively low long-term success rates. Catheter ablation of VT has
evolved from mapping and ablation of electrophysiologically defined
re-entrant circuits to the identification and targeting of abnormal myo-
cardial substrate (areas of scar and surrounding border zone contain-
ing a mixture of healthy and scar tissue). Although electrical
surrogates of arrhythmogenic myocardium are assessed by contact
electroanatomical mapping (EAM) of the endocardium and epicar-
dium, there are several limitations to this approach. Electroanatomical
mapping cannot interrogate the complex 3D anatomy of scar; the spa-
tial resolution of voltage-based mapping is limited by multiple factors
including electrode size, orientation, contact, and number of points
collected; electrical criteria for scar annotation may not be universally
applicable to pathological scar.4 In patients with non-ischaemic cardio-
myopathy who may have epicardial or intramural scar, the limitation
of EAM to delineate fully the 3D geometry of scar has been well
reported.5
Magnetic resonance imaging (MRI) using late-gadolinium enhance-
ment (LGE) is the gold standard for non-invasive imaging of scar/fi-
brosis.6 Late-gadolinium enhancement can be used for defining
myocardial substrate in 3D and potentially identify channels of slow
conduction prior to VT ablation.7 These can be channels between
areas of scar core or scar border zone (described as grey zone on
LGE-MRI), where there is a mixture of normal and scarred myocar-
dium and associated with slow conduction.8 In patients with non-
ischaemic cardiomyopathy with epicardial substrate, where
endocardial-only ablation is less likely to be successful, LGE-MRI has
been correlated to areas of low epicardial voltage and used to guide
epicardial ablation.9
Real-time MRI-guided EAM and ablation offers an attractive strat-
egy to improve the precision of substrate identification, provide
intraprocedural guidance, and facilitate assessment of ablation lesion
formation. Previous work in this area has focused on characterizing
correlations between MRI and EAM,10 device tracking (using passive
and active catheter tracking),11 assessment of electrogram fidelity in
the magnetic resonance (MR) environment,12 and lesion evaluation.13
To date, however, there are no studies evaluating epicardial mapping
and ablation under real-time MRI guidance.
In this study, we report the feasibility of performing epicardial map-
ping and ablation under real-time MRI guidance using active catheter
tracking in a porcine model. We also report on the use of real-time
lesion assessment with MR-thermometry for epicardial ablation,
hyper-acute lesion imaging with native T1 mapping and acute lesion
assessment with LGE.
Methods
Animal model and preparation
Animal studies complied with the French law on animal experiments
and were performed at the Institut de Chirurgie Guide´e par l’Image
(IHU), Strasbourg, France. Six female Landrace pigs (46.7 ± 10 kg)
were pre-sedated with a combination of intramuscular tiletamine and
zolazepam. General anaesthesia was induced and maintained with
inhaled 1–5% isoflurane, and the animals were intubated and mechan-
ically ventilated (20–25 breaths/min). Vascular access (7 Fr introducer
sheath) for invasive monitoring, and administration of medications
was obtained through the right and left femoral arteries and femoral
vein using ultrasound guidance. Epicardial access was gained using an
anterior percutaneous subxiphoidal puncture under X-ray guidance in
a fluoroscopy suite. A custom MR-compatible 10 Fr deflectable sheath
(Imricor, Burnsville, MN, USA) was placed within the pericardial space
for epicardial access. An MR-compatible steerable catheter of 9 Fr
with open irrigation (Vision-MR, Imricor, Burnsville, MN, USA) was
manoeuvred into the epicardial space. The catheters have been
described in detail previously.14 A custom MR-EP recording system
(Advantage-MR) consisting of a digital amplifier and stimulator, patient
information module, and a host workstation was used to record, dis-
play, and analyse intracardiac signals; to act as a programmable stimu-
lator; and to deliver ablation energy as previously described.14 All
animals underwent invasive blood pressure and surface electrocardio-
gram (ECG) monitoring (Invivo Medical, Gainesville, FL, USA)
throughout the study. Anticoagulation was maintained with an intra-
venous bolus of 70 units/kg of heparin. A continuous infusion of intra-
venous lidocaine (12 mL/h) and amiodarone (20 lg/kg/min) was
administered prior to mapping studies and ablation. A bolus of intra-
venous amiodarone (150 mg in 60 mls dextrose) was administered as
a slow push prior to each ablation lesion delivered. Animals were
transferred to an MRI suite following epicardial access for mapping
and ablation studies.
All MRI scans described below were performed on a 1.5 T MR scanner
(MAGNETOM, Aera, Siemens Healthcare, Erlangen, Germany).
Active catheter tracking
To project the location of the ablation catheter within the context of the
cardiac chambers, active catheter tracking using a dedicated MRI tracking
sequence, detected by microcoils within the catheter was used. A 3D
bSSFP whole heart volume was acquired at the start of the procedure
(described below), and manual chamber segmentations were performed
to provide an interface that closely mimicked that of a clinical EAM-style
system.
To perform active catheter tracking during MRI scans, the X, Y, Z co-
ordinates of the catheter microcoils were determined using a custom ac-
tive tracking sequence/module, which was optionally interleaved with a
What’s new?
• Epicardial activation and voltage maps were acquired under
real-time magnetic resonance imaging (MRI) guidance in vivo on
a large animal model solely using active catheter tracking.
High-quality intracardiac electrograms were recorded from
the epicardium during MR scanning with a signal-to-noise
ratio >10:1 for a signal of 1.5 mV.
• Quantitative thermal dose mapping during real-time MR-
thermometry allowed visualization and measurement of lesion
dimensions during epicardial ablation.
• Myocardial native T1 mapping measurements demonstrated
decreased T1 times in the ablation lesion core and elevated
T1 times in surrounding regions of ablated tissue (relative to
non-ablated tissue) within 3–5 min following delivery of epicar-
dial radiofrequency ablation.
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fast balanced steady-state free precession (bSSFP) imaging sequence
automatically following the current catheter position. The active tracking
sequence comprised three non-selective projection acquisitions along
the respective axis. A dynamic imaging coil detuning approach and pre-
spoiler were applied to avoid potential background noise, i.e. coil cou-
pling and residual signal effects. Based on the acquired projections, the
corresponding signal peaks were detected with a dynamic template-
matching algorithm, which used the initial projections to calculate a tem-
plate per coil and axis. The template was continuously updated with each
new projection fulfilling a minimal peak-to-noise ratio to adapt to the
changing shape of the projections while manoeuvring the catheter. The
detected positions were fed back to both the iCMR platform (Siemens
Healthcare) and the MRI scanner to update the rendered catheter pos-
ition/orientation and imaging plane location, respectively. The tracking
module was further optimized to run with an ambient acoustic noise and
had been found to perform robustly with an open MR cabin door, in the
presence of other electrical equipment (e.g. ventilator, ECG monitoring,
etc.) and during RF ablation.
3D whole heart sequence
A 3D, ECG-triggered whole-heart bSSFP acquisition with a 1D diaphrag-
matic navigator (5 mm gating window) was performed with the following
parameters: transverse slice orientation, AP phase encoding,
1.25 1.25 mm2 in-plane resolution, 256 256 in-plane matrix size,
2.5 mm acquired slice thickness reconstructed to 1.25 mm, typically
around 100 slices to cover the whole heart, TR/TE = 3.7/1.64 ms, flip
angle = 90, readout bandwidth (per pixel) = 592 Hz, fat suppression, and
GRAPPA acceleration factor = 2. The trigger delay was set so that the ac-
quisition was performed during mid-diastole, and the acquisition window
was set to correspond to the length of the diastolic period (typically
110 ms, corresponding to 30 k-space lines acquired per heartbeat).
Following acquisition, the left ventricle, right ventricle, left atrium, right
atrium, and aorta were manually segmented on each animal using an
image processing platform based on a version of Medical Imaging
Interaction Toolkit (MITK, Heidelberg, Germany) and saved as
Stereolithography (.STL) files. Segmentations were loaded on the iCMR
application (Siemens Healthcare) to create a road map for mapping and
ablation studies.
Epicardial mapping and ablation
Real-time intracardiac electrograms were recorded from the epicar-
dium and displayed using the Advantage-MR EP Recorder/Stimulator
System (Imricor Medical Systems, Burnsville, MN, USA; see
Supplementary material online, Figure S1). Each intracardiac electro-
gram (EGM) signal was displayed at 1 mV/cm to measure the peak-to-
peak signal amplitude and at 0.1 mV/cm to measure the peak-to-peak
noise amplitude. Epicardial voltage maps were displayed with thresh-
old of <1.5 mV. Once epicardial EGM fidelity in the MR environment
was demonstrated as feasible, we committed to delivering RF abla-
tions in remaining animals. Ablation of the left ventricle was per-
formed by delivering RF energy (40–60 W, irrigation rate 17 mL/min,
and 50–60 s duration). Impedance change and catheter tip tempera-
ture were continuously assessed. Ten discrete ablation lesions were
delivered in four animals with lesion position automatically recorded
in 3D space and annotated upon the 3D rendering of each heart on
the iCMR application. The aim was to create transmural lesions during
each discrete ablation. Using measurements on gross macroscopic
examination as the gold standard, conformational accuracy of lesion
annotation on the iCMR application was assessed using the angle of
intersection between points on two ablation lines measured to the
nearest degree. Spatial accuracy was referenced to the LV apex and
was measured to the nearest millimetre.
Cardiovascular magnetic resonance-
thermometry
Real-time lesion imaging could offer an attractive means to titrate energy
delivery which could potentially decrease overall procedural time, in-
crease efficacy, and reduce procedural risk during MR-guided EP proced-
ures. In this study, we employed cardiovascular magnetic resonance
(CMR)-thermometry using the proton resonance frequency shift (PRFS)
technique, which is sensitive to temperature changes in real time and has
been most widely studied in non-cardiac ablation.15
To perform CMR-thermometry, an ECG-triggered multi-slice single-
shot echo planar imaging (EPI) sequence was used with spoiled gradient
echo (TR/TE/a= 50 ms/17 ms/60 , FOV = 180 180 mm2, voxel
size = 1.6 1.6 mm2, slice thickness = 5 mm, slice number = 4,
bandwidth = 1565 Hz/Px, GRAPPA factor = 2, partial Fourier = 0.75,
orientation—short axis). Saturation slabs were used for reduced field of
view imaging and inflow saturation to reduce blood signal.16
Reconstruction of temperature maps was performed offline using a cus-
tomized multi-baseline approach extending the method previously pro-
posed15 as follows: a look up table of co-registered CMR-phase images
was initially created and the CMR-thermometry sequence was run for 20
heartbeats before each ablation. Images from the first heartbeat served as
the reference image. Non-rigid motion was then estimated between the
reference and each subsequent magnitude image using an optical flow
technique. Phase images were then registered to the reference position
using the estimated motion fields. The registration was performed on the
complex data instead of the phase images to prevent artefacts due to
phase wrap. During ablation, each new phase image was registered to the
reference, position as described above. The phase image from the lookup
table that best matched the current registered phase image (i.e. minimal
mean square error between pairwise unwrapped phase images) was then
selected and used for temperature estimation.
Cardiovascular magnetic resonance
dosimetry
During RF ablation, the ideal lesion will likely be transmural with no
extracardiac extension but create permanent tissue destruction to pre-
vent the recurrence of arrhythmia. There is only a small body of litera-
ture, however, demonstrating direct assessment of lesion formation
during RF delivery. Cardiovascular magnetic resonance-dosimetry
derived from MR-thermometry is a technique that can be used to provide
a real-time accumulated thermal dose (TD) during RF energy delivery at
the intended ablation point. Thermal dose mapping was calculated on a
pixel-wise basis as follows as previously described13:
TD ¼
ðt
0
2 TðtÞ-43ð Þdt if TðtÞ>43 C
ðt
0
4 TðtÞ-43ð Þdt if TðtÞ<43 C
;
8>>>>><
>>>>:
where TðtÞrepresents absolute tissue temperature. Baseline temperature
was approximated to 39 C. The TD was considered as lethal when ex-
ceeding the equivalent TD at constant heating of 43 C for 240 s. To cor-
rect for TD error induced by noise on temperature estimates, TD maps
were corrected on a pixel-wise basis as follows:
TDcorr ¼ TD  e-0:5 lnð2ÞrTð Þ;
where TDcorr is the corrected TD and rT is the temporal standard devi-
ation of temperature estimates at baseline (measured from the first 20
Epicardial mapping and ablation under MRI guidance 3
Downloaded from https://academic.oup.com/europace/advance-article-abstract/doi/10.1093/europace/eux341/4775038
by King's College London user
on 27 March 2018
measurements following the training thermometry step and before the
heating process). Width and depth of lesion estimated from TD mapping
were measured from the middle slice containing the largest lethal dose
area.
Native T1 mapping
The longitudinal relaxation time constant (T1) of the myocardium is
known to be altered following RF ablation.17 Post-procedural MRI using
native T1 mapping therefore presents an opportunity for the assessment
of ablation injury. The modified Look-Locker (MOLLI) sequence was
used for native myocardial T1 mapping using a 5-(3)-3 scheme and a
bSSFP readout (TR/TE/a= 2.5 ms/1.2 ms/35 , FOV = 360 307 mm2,
voxel size = 1.4 2.1 mm2, slice thickness = 8 mm, bandwidth = 1085 Hz/
Px, GRAPPA factor = 2, partial Fourier = 0.87). Average T1 times were
measured in regions of interest (ROIs) manually drawn on the MOLLI
scans in areas of ablated tissue. Similarly, reference T1 measurements
were calculated for the remote LV myocardium in non-ablated tissue by
drawing ROIs on the anteroseptal wall. Approximate lesion location iden-
tified on T1 mapping was correlated with lesion location identified on
LGE imaging.
Late-gadolinium enhancement imaging
High-resolution 3D LGE imaging was performed using a free-breathing
navigator-gated inversion recovery gradient echo (GRE) sequence (TR/
TE/a= 5.45 ms/1.8 ms/10 , FOV = 339 264 100 mm3, voxel size = 1
.3 1.3 4 mm3, bandwidth = 360 Hz/Px, GRAPPA factor = 2, 2RR
acquisition). Magnevist (gadopentetate dimeglumine) (Bayer, Germany)
0.1 mmol/kg was administered following completion of all ablation lesions
and the imaging sequence run 10–15 min following contrast
administration.
Histological analysis
Following euthanasia (performed immediately after completion of map-
ping and ablation studies), hearts were explanted, photographed, and
fixed in 10% formalin. The ablation lines and surrounding tissue were
excised en bloc and cut into sections perpendicular to the ablation line.
Lesions were photographed, while depth and width was measured with a
ruler and dimensions correlated to those observed on 2D TD maps.
Each cross-section was dehydrated, embedded in paraffin, sectioned
(6lm sections), and then stained with haematoxylin and eosin.
Statistical analysis
Data analysis was performed using GraphPad Prism 7 (GraphPad Prism,
San Diego, CA, USA). Data were displayed as mean ±standard deviation.
Differences between groups were analysed using independent Student’s
t-test for unpaired data. The value of P< 0.05 was considered statistically
significant.
Experimental ethics and reporting
The experimental protocol in the animal model was approved by the
local ethics committee and was compliant with the Guiding Principles for
the Use and Care of Animals published by the National Institutes of
Health (NIH Publication no. 85-23, Revised 1996).
Results
Epicardial mapping was performed solely under real-time MRI guid-
ance with active catheter tracking in two animals. The total procedural
time to complete epicardial mapping was 32 min (101 points) in the
first animal (Figure 1) and 20 min (56 points) in the second animal.
High-quality intracardiac electrograms were recorded in the MR
environment to build the EAMs Representative results of the
electrogram signal quality are shown in Figure 1—a peak-to-peak amp-
litude of 14.56 mV is seen for a typical epicardial signal. A mean signal-
to-noise ratio of 32.8 (±14.9) was calculated for epicardial points
taken. For a signal (low voltage) of 1.5 mV, a noise level of 0.14 mV was
seen with a better than 10:1 signal-to-noise ratio observed (Figure 1).
A further four animals had 10 discrete RF ablations delivered on
the epicardium (40–60 W for 50–60 s duration) with catheter naviga-
tion performed solely with active tracking. Ablation lesions annotated
on the anatomical shells (iCMR application, Siemens Healthcare) cor-
responded well with post-ablation lesion location on autopsy
(r= 0.97) with a mean spatial accuracy of 2.2 mm (±1.5 mm) and a
mean conformational accuracy of 4.4 (±1.8) (see Supplementary
material online).
Real-time lesion visualization
MR-thermometry and dosimetry was able to demonstrate a localized
temperature elevation near the catheter tip during delivery of epicar-
dial RF ablation. A maximum temperature difference of 35 C (rela-
tive to pixel in area of more remote septum) was observed within
2 mm of the irrigated catheter tip, while a lower temperature differ-
ence was observed further away from the catheter tip in the myocar-
dium and no temperature change in a more remote area of
myocardium >8 mm away from the catheter tip (Figure 2).
Hyper-acute and acute lesion
visualization
Mean native T1 time in the core of ablation lesions was decreased
(relative to non-ablated myocardium) at 882 ms (±107 ms) while in
surrounding tissue, mean native T1 times were elevated at 1316 ms
(±85 ms). In remote, non-ablated tissue, mean native T1 times were
1028 ms (±64 ms) (Figure 3). Areas of elevated native T1 times
matched well with areas of hyper-enhancement on LGE images and
to lesion location on pathological examination (see Supplementary
material online).
Gross macroscopy and histology
On gross macroscopy, a zone of pallor could be clearly delineated
corresponding to the ablation lesion core with a surrounding haem-
orrhagic zone (see Supplementary material online). Lesion transmur-
ality of >75% was seen in 9 of 10 ablation lesions. For measurement
of lesion dimensions, the ablation lesion was defined as both the zone
of pallor and the surrounding oedematous zone. Figure 2 illustrates
representative short-axis images on MR-dosimetry to measure lesion
dimensions with corresponding lesion delineation on gross macro-
scopy. Lesion dimensions measured using MR-dosimetry matched
well to dimensions on gross macroscopy with mild overestimation
(Figure 2). Microscopic histology of acute ablation injury on haema-
toxylin and eosin staining demonstrated partial loss of membrane
borders, nuclear elongation, and interstitial oedema (see
Supplementary material online).
Discussion
This study demonstrates the feasibility of using real-time MRI guid-
ance to perform epicardial activation/voltage mapping and RF
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ablation using active catheter tracking in a porcine model.
Estimated lesion dimensions by real-time MR-dosimetry during
epicardial RF ablation corresponded to gross macroscopy. Native
T1 time decreased in the lesion core and was elevated in the sur-
rounding areas of ablated tissue within minutes of delivering epi-
cardial RF ablation.
Demonstration of intracardiac EGM
fidelity
The accurate detection of cardiac electrical activity is difficult in the
MR environment in part due to the presence of time variable gradient
fields and magnetohydrodynamic (MHD) effects. Intracardiac
electrograms may be high-pass and low-pass filtered, often requiring
a further notch filter to reduce gradient signal-induced noise of
intracardiac electrograms. Elbes et al.18 found that the ‘noise’ ampli-
tude inside the MR environment varied according to the type of se-
quence, slice orientation, gradient amplitude, and switching times
with a peak-to-peak noise amplitude ranging from 0.025 to 0.700 mV.
Nazarian et al.12 reported a filtered ventricular electrogram SNR of
71.6 compared with an unfiltered SNR of 3.7 in the endocardial RV
apex using active catheter tracking in mongrel dogs.
To the best of our knowledge, there are no studies investigating
intracardiac EGM fidelity during epicardial mapping under real-
time MRI guidance solely with active catheter tracking. Epicardial
substrate mapping is arguably more challenging than endocardial
Figure 1 Intracardiac EGM signal quality, epicardial activation, and voltage maps. (A) Representative intracardiac EGM from the epicardium show-
ing a peak amplitude of 14.56 mV (0.97 mV noise level)—sweep speed 100 mm/s. (B) For a low voltage 1.5 mV signal, a noise level of 0.136 mV is pre-
sent giving a >10:1 signal-to-noise ratio. (C) Epicardial activation map in swine in sinus rhythm generated using active catheter tracking only in the MR
environment. (D) Epicardial voltage map with threshold set between 0.5 mV and 1.5 mV. (E) Epicardial voltage map with a threshold set between
4.0 mV and 8.0 mV. 3D shells shown were created following segmentation of the whole heart sequence from MRI and imported into the iCMR appli-
cation. Activation and voltage map data were superimposed onto the anatomical shells.
Epicardial mapping and ablation under MRI guidance 5
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mapping due to the presence of epicardial fat and low-voltage
areas along the course of large coronary arteries and the atrio-
ventricular (AV) groove, affecting the reliability of electrograms
recorded.9 Our study demonstrates that it is feasible to detect a
good signal quality during epicardial mapping in the MR environ-
ment with an acceptable noise level and a >10:1 signal-to-noise
ratio for low-voltage signals.
Demonstration of MR-EP tracking and
therapy accuracy
The use of active catheter tracking with a dedicated tracking se-
quence, detected by microcoils in a MR-compatible catheter has
been employed previously.19 The microcoil method is advantageous
due to its ability to track multiple coils along the body of the catheter,
Figure 2 In vivo Dtemperature maps (A) shown at different time points relative to the start of the RF heating. Localized temperature elevation can
be clearly visualized on the epicardial side of the left ventricle. Temporal profiles (B) obtained using CMR-thermometry during epicardial ablation in
swine. A maximum temperature elevation of 35 C was observed in a pixel within 2 mm of the catheter tip—Point 1 (relative to a more remote pixel
in myocardium >8 mm away from the catheter tip—Point 3). No significant temperature elevation was observed in a pixel located in a remote area.
2D lesion dimensions measured using MR-dosimetry (C) correlate well with measurements on gross macroscopy with mild overestimation of lesion
width.
6 R.K. Mukherjee et al.
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a faster rate of tracking and choice of guidance using acquired road
maps or real-time imaging.19 Grothoff et al.14 reported the use of ac-
tive catheter tracking to guide intubation of the coronary sinus, trans-
septal puncture, activation mapping of the left atrium, and ablation of
the AV node in pigs. Catheter position was confirmed by passive
real-time imaging. We have previously demonstrated the feasibility of
real-time MRI-guided catheter ablation in patients with typical atrial
flutter using active catheter tracking.19 Using a combination of active
tracking and catheter visualization with real-time MR imaging, Hilbert
et al.11 also performed cavotricuspid isthmus ablation in six patients
with a mean procedural time of 109± 58 min. Complete isthmus
block was achieved in three of six patients without additional fluoros-
copy. There are little data, however, demonstrating the accuracy of
epicardial RF ablation in a real-time MR environment, even in pre-
clinical models.
In this study, following demonstration of the feasibility of epicardial
mapping and ablation using active catheter tracking, progress has
been made on a complete MR-based solution for VT substrate
modification.
Real-time lesion visualization
There has been significant interest in the development of MR tools to
assess ablation lesions in real time. Direct monitoring of tissue tem-
perature using MR-thermometry and dosimetry offers an exciting
means of exploiting acute physiological changes and could potentially
be used to improve the safety and efficacy of catheter ablation.
Kolandaivelu et al.20 first described the use of MR-thermometry using
the proton resonance frequency (PRF) shift technique to quantify tis-
sue temperature changes that lead to ablation lesion formation. In
mongrel dogs, the maximum ablation lesion extent during endocar-
dial RF ablation on MR-thermometry corresponded well to the lesion
location, depth on LGE-MRI, and pathological examination.20 Lesion
transmurality with MR-thermography was within 20% of that meas-
ured by pathology and LGE-MRI. Recently, in an ovine model, Toupin
et al.13 demonstrated that endocardial ablation lesion dimensions on
TD images correlated well with 3D T1-weighted images acquired im-
mediately after ablation and during gross pathological examination.
The precision of lesion extent in the myocardium was in the region
of 1 mm—potentially offering a useful MR tool in real time to guide
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Figure 3 Native T1 maps at six slices (apical to basal) 3–5 min following delivery of an ablation lesion (A) decreased T1 times were seen in the le-
sion core whilst elevated T1 times were seen in the surrounding tissue relative to non-ablated myocardium (ablation lesion core in white arrows).
Mean native T1 time in the lesion core was 882 ms (±107 ms), in surrounding tissue was 1316 ms (±85 ms), and 1028 ms (±64 ms) in remote, non-
ablated tissue (B); n= 10 lesions; *P< 0.05.
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the safety and efficacy of RF ablation. Our report extends the use of
this technique to provide an assessment of epicardial lesion extent
during RF ablation. Further work is still needed, however, to assess
how real-time lesion imaging relates to chronic transmural lesions—a
porcine recovery model of ventricular ablation could be used to con-
firm long-term efficacy in future studies. In our study, the TD model
was used for the prediction of ablation lesions. Other approaches
have also been proposed such as using the maximum temperature
peak for each voxel.13,20 Further work is needed to establish the
most accurate model for the prediction of permanent ablation
lesions.
Hyper-acute and acute lesion
visualization
Our data indicate that within minutes of RF ablation, there is a de-
crease in native T1 time in the lesion core and an overall localized ele-
vation in native T1 times at the surrounding areas of ablation lesions
compared with areas of non-ablated tissue. Although there are few
studies investigating the use of native T1 mapping to visualize the ef-
fect of RF ablation within this time frame, it has been suggested that
catheter ablation induces changes in native tissue T1 time.17
Following catheter ablation, there may be several types of tissue in-
jury present within the lesion core and surrounding areas including
necrotic tissue, haemorrhage, oedema, and thrombus. Recent work
suggests that in vivo MOLLI measurements show different T1 times at
the lesion core (decreased T1) and lesion periphery (increased T1)
when imaging is performed within 2 h of ablation in a porcine mod-
el.17 Due to the different types of tissue injury involved, it may be in-
appropriate to evaluate ablation lesions using an overall mean native
T1 time in ablated zones. Further, native T1 mapping may also be in-
appropriate to assess ablation lesions in patients with non-ischaemic
cardiomyopathy where differences in T1 times may exist between
relatively healthy and diseased segments of myocardium due to the
underlying cardiomyopathy making interpretation difficult following
ablation. Further work is required in this area to assess the effects of
RF ablation on native T1 times at different time-points after ablation
with histopathological validation.
Of the different approaches described in this study, to assess acute
ablation injury (thermometry/dosimetry, native T1 mapping, and
LGE), thermometry remains the only technique with the ability to as-
sess lesions in real-time. To facilitate the real-time MR-guided abla-
tion, thermometry would be our preferred approach for lesion
assessment. However, there are several limitations to the technique
in its current form that need to be overcome (described below).
Limitations
There are several important limitations to this work. The purpose of
this preliminary study was to demonstrate the feasibility of perform-
ing epicardial mapping and ablation under real-time MRI guidance
with active catheter tracking in a pre-clinical setting. As such, the epi-
cardial electroanatomical maps generated were of a low resolution
(101 and 56 points) and only obtained in normal hearts. Further
work is required to assess the procedural time of high-resolution epi-
cardial activation and voltage maps under real-time MRI guidance,
ideally in an animal model with areas of scar and low voltage.
Following ventricular RF ablation, large animal models frequently
become tachycardic and/or develop ventricular arrhythmias that may
affect the quality of the myocardium, blood, and phase signal during
MR-thermometry. MR-thermometry in the presence of irregular
heart rhythm was not evaluated in this study, and its feasibility re-
mains to be established. Further refinements in the thermometry
technique may be needed to overcome these limitations. We did not
evaluate chronic ablation injury in this model; therefore, further work
is needed to evaluate whether TD achieved during acute lesions cor-
responds to permanent lesion formation in a recovery model. The
sensitivity and specificity of MR-thermometry for lesion monitoring
during ablation was not assessed, while the limited number of lesions
delivered precluded our ability to assess whether the extent of tem-
perature rise could be predictive of lesion transmurality—these areas
could be an important focus of future work. The thermometry data
required post-processing offline to generate the data on lesion di-
mensions. For the data to be useful to the electrophysiologist, a real-
time pipeline with visualization of the TD onto an anatomical shell
and demonstration of lesion dimension needs to be developed to
guide catheter ablation although this was beyond the scope of this
preliminary work. To facilitate VT ablation under MRI guidance in pa-
tients, there are still significant hurdles to overcome such as the avail-
ability of MRI-conditional defibrillation systems and MR-compatible
12-lead ECG systems. Patients undergoing VT ablation frequently re-
quire defibrillation—the time delay associated with removing a pa-
tient from the scanner bore before delivery of cardiopulmonary
resuscitation and defibrillation could potentially increase the risk of
mortality. Although there are prototype MR-compatible defibrillation
systems currently undergoing testing, until there are robust systems
that are shown to be successfully able to defibrillate patients without
increasing the time needed for defibrillation, the uptake of higher risk
MR-guided interventions is likely to be limited.
Conclusion
This study demonstrates the feasibility of epicardial electroanatomical
mapping and ablation under real-time MRI guidance with active cath-
eter tracking in the porcine left ventricle. MR-thermometry and dos-
imetry enabled the real-time visualization of ablation injury and
measurement of lesion dimensions whilst changes in native T1 times
were observed within minutes of lesion delivery.
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Supplementary material is available at Europace online.
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